Q3 2022 Alpine Immune Sciences Inc Earnings Call Transcript
Please stand by. Welcome to the Alpine Immune Sciences third-quarter earnings call. Currently, all participants are in a listen-only mode. As a reminder, this event is being recorded.
I would now like to introduce Temre Johnson, Senior Director of Investor Relations and Corporate Communications at Alpine. Ms. Johnson, I will now turn the call over to you.
Thank you, operator. Good afternoon, and thank you for joining us. With me on today's call are Dr. Mitchell Gold, Executive Chairman and Chief Executive Officer; Dr. Stanford Peng, President and Head of R&D; Dr. Andrew Sandler, Chief Medical Officer; Paul Rickey, Chief Financial Officer; and Dr. Remy Durand, Chief Business Officer.
Before I turn the call over to Mitch, I would like to remind you that we'll be making forward-looking statements during the course of today's call. I encourage you to refer to the most recent SEC filings regarding the risk factors associated with these statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |